FTSE MIB
33.154,05 -32,84 (-0,10%) Dow Jones
39.118,86 -45,20 (-0,12%) Nasdaq
17.732,60 -126,08 (-0,71%) Nikkei 225
39.583,08 +241,54 (+0,61%) Petrolio
81,46 -0,28 (-0,34%) Bitcoin EUR
56.567,48 -1.064,34 (-1,85%)
PGNY Jul 2024 22.500 call
| Chiusura precedente | 3,4000 |
| Aperto | N/D |
| Denaro | 4,5000 |
| Domanda | 8,5000 |
| Prezzo d'esercizio | 22,50 |
| Scadenza | 2024-07-19 |
| Min-Max giorno | 3,4000 - 3,4000 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 8 |
GlobeNewswireProgyny Celebrates More Than 30,000 Amazonians Supported on Their Family Building Journeys
Amazon’s comprehensive family building benefit offered through Progyny to be recognized at RESOLVE’s Night of Hope GalaNEW YORK, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced their nearly five-year partnership with Amazon has reached a milestone number of more than 30,000 individuals and families being supported on their family building journeys. Since 2019, A
- GlobeNewswire
Progyny Unveils Nationwide Access to Menopause Care
Integrative approach with leading providers Gennev and Midi Health to advance equitable and accessible workplace support for individuals experiencing menopause symptomsNEW YORK, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced the strategic expansion of its extensive managed reproductive health network to include specialized providers of menopause care. Progyny’s
- GlobeNewswire
Progyny, Inc. Announces Second Quarter 2023 Results
Reports Record Quarterly Revenue of $279.4 Million, Reflecting 43% Growth Over the Prior Year PeriodAchieves Record Quarterly Operating Cash Flow of $76.0 MillionRaises Full Year Revenue and Earnings GuidanceContinuing to See Strong Employer Demand for Fertility and Family Building Solutions NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions,
